Mitophagy reduces AD-related tau hyperphosphorylation and prevents cognitive impairment, indicating that impaired clearance of defective mitochondria is a key event in AD pathogenesis and that mitophagy could be a potential therapeutic target (141). The gene discussed is MAPT; the disease is Alzheimer disease.